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Abstract
Background: Gum resins obtained from trees of the Burseraceae family (Boswellia sp.) are important ingredients in
incense and perfumes. Extracts prepared from Boswellia sp. gum resins have been shown to possess anti-
inflammatory and anti-neoplastic effects. Essential oil prepared by distillation of the gum resin traditionally used for
aromatic therapy has also been shown to have tumor cell-specific anti-proliferative and pro-apoptotic activities. The
objective of this study was to optimize conditions for preparing Boswellea sacra essential oil with the highest
biological activity in inducing tumor cell-specific cytotoxicity and suppressing aggressive tumor phenotypes in
human breast cancer cells.
Methods: Boswellia sacra essential oil was prepared from Omani Hougari grade resins through hydrodistillation at
78 or 100
oC for 12 hours. Chemical compositions were identified by gas chromatography-mass spectrometry; and
total boswellic acids contents were quantified by high-performance liquid chromatography. Boswellia sacra
essential oil-mediated cell viability and death were studied in established human breast cancer cell lines (T47D,
MCF7, MDA-MB-231) and an immortalized normal human breast cell line (MCF10-2A). Apoptosis was assayed by
genomic DNA fragmentation. Anti-invasive and anti-multicellular tumor properties were evaluated by cellular
network and spheroid formation models, respectively. Western blot analysis was performed to study Boswellia sacra
essential oil-regulated proteins involved in apoptosis, signaling pathways, and cell cycle regulation.
Results: More abundant high molecular weight compounds, including boswellic acids, were present in Boswellia
sacra essential oil prepared at 100
oC hydrodistillation. All three human breast cancer cell lines were sensitive to
essential oil treatment with reduced cell viability and elevated cell death, whereas the immortalized normal human
breast cell line was more resistant to essential oil treatment. Boswellia sacra essential oil hydrodistilled at 100
oC
was more potent than the essential oil prepared at 78
oC in inducing cancer cell death, preventing the cellular
network formation (MDA-MB-231) cells on Matrigel, causing the breakdown of multicellular tumor spheroids (T47D
cells), and regulating molecules involved in apoptosis, signal transduction, and cell cycle progression.
Conclusions: Similar to our previous observations in human bladder cancer cells, Boswellia sacra essential oil
induces breast cancer cell-specific cytotoxicity. Suppression of cellular network formation and disruption of
spheroid development of breast cancer cells by Boswellia sacra essential oil suggest that the essential oil may be
effective for advanced breast cancer. Consistently, the essential oil represses signaling pathways and cell cycle
regulators that have been proposed as therapeutic targets for breast cancer. Future pre-clinical and clinical studies
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treating breast cancer.
Background
Frankincense is an aromatic resin hardened from exuded
gums obtained from trees of the genus Boswellia (Burser-
aceae family). Boswellia sp. includes Boswellia sacra from
Oman and Yemen, Boswellia carteri from Somalia, and
Boswellia serrata from India and China. The resin has
been used in incense and fumigants, as well as a fixative
in perfumes. Aroma from these resins is valued for its
superior qualities for religious rituals since the time of
ancient Egyptians [1]. Boswellia sp. resins have also been
considered throughout the ages to have a wealth of heal-
ing properties. For example, resins of Boswellia sp.h a v e
been used for the treatment of rheumatoid arthritis and
other inflammatory diseases [2] such as Crohn’s disease
[3]. The anti-inflammatory activity has been attributed to
the resin’s ability in regulating immune cytokine produc-
tion [4] and leukocyte infiltration [5,6]. Extracts from
Boswellia sp. have been shown to possess anti-bacterial,
anti-fungal [7], anti-carcinogenic [8], and anti-neoplastic
[9,10] properties. Clinically, extracts from the resin have
been shown to reduce the peritumoral edema in glioblas-
toma patients [9] and reverse multiple brain metastases
in a breast cancer patient [11]. These results suggest that
resins from Boswellia sp. contain active ingredients that
modulate important biological and health supporting
activities.
Boswellic acids have been identified as a major chemi-
cal component in Boswellia sp. extracts that provide the
anti-inflammatory activity. Chevrier et al.r e p o r t e dt h a t
ethanol extracts of Boswellia carteri gum resins com-
prise 7 boswellic acids [4]. Akihisa et al.r e p o r t e dt h a t
methanol extracts of Boswellia carteri resins consist of
15 triterpene acids including boswellic acids [12].
Acetyl-11-keto-b-boswellic acid (AKBA), being sug-
gested as the most potent anti-inflammatory component
from the resins, selectively blocks leukotriene biosynth-
esis through inhibiting 5-lipoxygenase activity [13].
AKBA provides protective effects in a chemically
induced mouse ulcerative colitis model [14]. Boswellic
acids including AKBA have also been proposed to pro-
vide anti-neoploastic activity through their anti-prolif-
erative and pro-apoptotic properties in multiple human
cancer cell lines including meningioma cells [15], leuke-
mia cells [16], hepatoma cells [17], melanoma cells,
fibrosarcoma cells [18], colon cancer cells [19], and
prostate cancer cells [20-22].
Boswellia sp. essential oil, an extract prepared by distilla-
tion of frankincense gum resins, is one of the most com-
monly used essential oils in aromatherapy. Considerable
amount of work has been attempted to identify chemical
compositions of Boswellia sp. essential oils from different
commercial brands. Chemical constituents of Boswellia sp.
essential oils differ significantly due to climates, time of
harvest, storage conditions, geographical sources of resins
[23], and methods of preparations. In this study, Boswellia
sacra gum resins were collected in Oman; and essential oil
was prepared via hydrodistillation at 78 or 100
oCf o r1 2
hours. Chemical profiles of these essential oils were ana-
lyzed. These essential oils were studied for their anti-
tumor properties in a panel of human breast cancer cell
lines and an immortalized normal breast epithelial cell
line. Boswellia sacra essential oil-regulated Akt and ERK1/
2 activation, cyclin D1 and cdk4 expression, and caspases
activation were also assessed.
Methods
Reagents and chemicals
Cell culture media (RPMI 1640, MEM, Leibovitz’sL - 1 5 ,
and DMEM/F-12), fetal bovine serum (FBS), horse
serum, sodium pyruvate, MEM non-essential amino acids
(NEAA), epidermal growth factor (EGF), cholera toxin,
insulin, hydroxortisome, and penicillin-streptomycin
were purchased from Invitrogen (Grand Island, NY).
XTT cell proliferation assay and lactate dehydrogenase
(LDH) cytotoxicity detection kits were obtained from
Roche Applied Science (Indianapolis, IN). Matrigel™
basement membrane matrix was purchased from BD
Biosciences (Bedford, MA). NanoCulture
® plate and
m e d i aw e r eo b t a i n e df r o mS C I V A XC o r p .( K a n a g a w a ,
Japan). Bicinchoninic acid (BCA) protein assay kit was
purchased from Thermo Scientific Pierce (Rockford, IL).
Rabbit anti-phospho-Akt (protein kinase B; PKB)
(Ser473) antibody, rabbit anti-phospho-p44/42 MAP
kinase (ERK1/2) (Thr202/Tyr204) antibody, mouse anti-
cyclin D1 monoclonal antibody, mouse anti-cdk4 mono-
clonal antibody, mouse anti-human caspase-8 monoclo-
nal antibody, rabbit anti-human caspase-9 polyclonal
antibody, rabbit anti-cleaved caspase-3 (Asp175) mono-
clonal antibody, and rabbit anti-poly (ADT-ribose) poly-
merase (PARP) polyclonal antibody were purchased from
Cell Signaling Technology (Danvers, MA). Mouse anti-
human pro-caspase-3 monoclonal antibody was obtained
from abcam (Cambridge, MA). Mouse anti-b-actin anti-
body was obtained from Sigma (St. Louis, MO).
Boswellia sacra essential oil preparation
Hougari grade Boswellia sacra gum resins were obtained
from the Hasik area to the east of Salalah City, Oman.
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portions and hydrodistilled at two temperatures, 78 or
100
oC, at roughly atmospheric pressure in Salalah City.
Briefly, hydrodistillationw a sp e r f o r m e di nac u s t o m
made hydrodistiller. Boswellia sacra resins were loaded
into 55
oC water with a ratio of 1:2.5 (w/v), and mixed
with an electromechanical agitator for 30-45 min or
until a thick homogenous mucilage was formed. Tem-
peratures of the hydrodistiller were monitored by an
infrared thermometer; and pressures were recorded at
the condenser terminal. To remove any residual water,
collected Boswellia sacra essential oil was immediately
transferred into a -20
oC freezer; and ice crystals were
separated from the essential oil.
Chemical analysis of Boswellia sacra essential oil using
gas chromatography-mass spectrometry (GC-MS)
Chemical components of the essential oils were analyzed
with a 7890 GC-MS (Agilent Technologies, Santa Clara,
CA) equipped with an HP-1 column (50 m × 0.32 mm
× 0.5 um). GC oven temperature was set and main-
tained at 80
oC for 2 min and programmed to 250
oCa t
a rate of 3
oC/min. The oven temperature was then pro-
grammed to 290
oCa tar a t eo f1 0
oC/min and main-
tained for 15 min. An aliquot (1 µl) of essential oil was
injected at a 1:125 split ratio with injector and detector
temperatures at 250
oC with He as the carrier gas at 1.3
ml flow. MS was performed using a 5973 GC-MSD
(Agilent Technologies) with an ionization voltage of 70
eV. Comparison of mass spectra for identification pur-
poses used an essential oil database from CNRS (Lyon,
France) as well as Wiley and NIST mass spectral
libraries. Retention index calculations utilized C6 to C30
alkanes.
Quantification of boswellic acids contents
Analysis of total boswellic acids contents in the essential
oils was provided by San Rafael Chemical Services (Salt
Lake City, UT). Briefly, a weighed portion of the sample
was diluted in methanol, filtered, and then analyzed by
high-performance liquid chromatography (HPLC) model
1090 II/L (Hewlett Packard) with synergi hydro-RP, 150
× 3.0 mm, 4 μm, 80 Å columns. Boswellic acids were
detected by a photodiode array detector, scanning from
190 to 600 nm; and quantification was performed at
205 nm.
Human breast cell lines
Human breast cancer T47D (HTB-133), MCF-7 (HTB-
22), and MDA-MB-231 (HTB-26) cells as well as
immortalized normal breast epithelial MCF-10-2A
(CRL-10781) cells were purchased from ATCC (Mana-
ssas, VA). T47D cells were isolated from pleural effusion
of a female patient with an infiltrating ductal carcinoma
of the breast [24]. This cell line is estrogen receptor
(ER) positive and cultured in RPMI 1640 plus 10% FBS
and 1% sodium pyruvate. MCF-7 cells were derived
from pleural effusion of breast adenocarcinoma from a
female patient [25]. This cell line is ER-positive and cul-
tured in MEM supplemented with 1% MEM NEAA, 1
mM sodium pyruvate, 10% FBS, and 10 ng/ml insulin.
MDA-MB-231 cells were establi s h e df r o mp l e u r a le f f u -
sion of a female patient diagnosed with adenocarcinoma
[26], and maintained in Leibovitz’s L-15 medium supple-
mented with 10% FBS. The immortalized normal MCF-
10-2A breast cell line was derived from a patient with
fibrocystic breast disease, and is non-tumorigenic in
immunodeficient mice [27]. MCF-10-2A cells is main-
tained in DMEM/F-12 plus 5% horse serum, 20 ng/ml
EGF, 100 ng/ml cholera toxin, 10 ng/ml insulin, and
500 ng/ml hydroxortisome. All culture media also sup-
plemented with 100 units/ml penicillin-100 µg/ml strep-
tomycin. Cells were cultured in a humidified cell
incubator at 37
oCa n d5 %C O 2 and passaged every 3-4
days or when cells reached about 80% confluence.
Cell growth and viability assay
Cell proliferation was determined in the breast cancer
cell lines and immortalized MCF10-2A cells in their
growth media. Cells (1x10
3) were seeded into each well
of 96-well tissue culture plates in 200 µl growth media;
and viable cells were quantified between 1 and 4 days
after seeding using the XTT cell proliferation assay kit.
Briefly, 100 µl culture medium was removed from each
well at the time of assay, and an aliquot of 50 µl XTT
labeling mixture was added back to each well [28]. Reac-
tions were performed at 37
oC for 4 hours. Absorbance
was read at 450 nm wavelength using a µQuant micro-
plate reader (Bio-Tek; Winooski, VT). To determine
Boswellia sacra essential oil-suppressed cell viability, the
breast cell lines were seeded at 5x10
3 cells/well in 100
µl growth medium in 96-well tissue culture plates. Fol-
lowing overnight adherence, cells either received addi-
tional 100 µl growth media (untreated controls) or
varying dilutions (1:200 to 1:2,700) of essential oil in
growth media. Cell viability was determined using the
XTT cell proliferation assay at 24 hours following essen-
tial oil exposure. Numbers of viable cells were calculated
from standard curves with known numbers of cells run
in parallel. Results were presented as average numbers
of viable cells for cell growth and essential oil-sup-
pressed cell viability.
Cell cytotoxicity assay
Boswellia sacra essential oil-induced breast cell death
w a sq u a n t i f i e db yr e l e a s e dL D Ha c t i v i t yi nc u l t u r e
media from damaged cells. Conditions for cell seeding
and essential oil treatment were identical to the cell
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quot of 100 µl medium was removed from each well
and transferred to new 96-well plates. An aliquot of 100
µl LDH cytotoxicity detection reagent was added to
each well and incubated for 15 min at room tempera-
ture. Absorbance was measured at 492 nm using the
µQuant microplate reader. Numbers of damaged cells
were calculated from standard curves established from
known numbers of cells incubated with the cell lysis
solution provided by the manufacture. Results were pre-
sented as average numbers of damaged cells for each
essential oil preparation.
Genomic DNA fragmentation
To determine Boswellia sacra essential oil-induced
apoptosis in breast cancer cells, chromosomal DNA
fragmentation, a biochemical hallmark of apoptosis, was
performed. Breast cancer cells (3 × 10
5) were seeded in
60 mm tissue culture plates in their growth media, incu-
bated overnight for adherence, and treated with varying
dilutions of essential oils obtained at 78 and 100
oC
hydrodistillation, respectively. Cells were harvested at 0
(untreated control), 2, 4, and 8 hours following treat-
ment; and genomic DNA was isolated and precipitated
based on reported procedures [29]. Total genomic DNA
isolated from each sample was subjected to RNase A (10
μg/ml) digestion followed by size separation on 2% agar-
ose gels. The gels were stained with 0.5 µg/ml ethidium
bromide; and images of the stained gels were captured
by the Gel Doc 100 system (Bio-Rad; Hercules, CA).
Matrigel invasion assay
To determine the capability of Boswellia sacra essential
oil in suppressing breast cancer cell invasion, a modified
in vitro Matrigel outgrowth assay was utilized [30].
Briefly, an aliquot (100 µl) of liquefied Matrigel base-
ment membrane matrix was transferred to each well of
96-well culture plates and allowed to polymerize at 37
oC for 30 min. Breast cancer cells were trypsinized; and
an aliquot of 2 × 10
4 or 4 × 10
4 cells was either resus-
pended in 100 µl growth medium alone or 100 µl
growth medium containing varying dilutions of essential
oils. After overnight incubation, cell spreading and
invading into Matrigel matrix were imaged with a Nikon
Eclipse TE 2000-S inverted microscope using a digital
CCD camera (Roper Scientific, Sarasota, FL) equipped
with NIS-Elements AR 3.0 imaging software. XTT assay
was then performed in the same wells to determine the
viability of essential oil-treated breast cancer cells on
Matrigel.
Spheroids formation assay
To evaluate and predict breast cancer cell responses to
Boswellia sacra essential oil, multicellular tumor
spheroids, an in vitro model for simulating three-dimen-
sional tumor micro-milieu [31], were applied. Breast
cancer cells (1 × 10
4) were seeded into each well of the
96-well NanoCulture
® plates in 50 µl growth medium
for spheroids formation. Cells were then either left
untreated or treated with varying dilutions of essential
oils at 48 hours post seeding. At 24 hours following
essential oil treatment, images of multicellular spheroids
were visualized and captured with the Nikon inverted
microscope and imaging software.
Western blot analysis
Boswellia sacra essential oil-regulated target proteins
activation and expression were analyzed using Western
blotting. Briefly, 5x10
5 breast cells were seeded in 60
mm tissue culture plates and exposed to either 1:800 or
1:1,200 dilutions of essential oils obtained at 78 or 100
oC, respectively. Cells were then harvested at designated
time points by lysing the cells with RIPA buffer supple-
mented with 0.1 mM phenylmethylsulphonylfluoride
(PMSF), complete mini-protease inhibitor cocktail, and
PhosSTOP phosphatase inhibitor Cocktail (Roche
Applied Science). Following centrifugation, total cellular
proteins were collected; and protein concentration was
quantified by the BCA protein assay kit. An aliquot (30
µg) of the total cellular proteins from each sample was
separated on 10% Tris-HCl gel (Bio-Rad); and the sepa-
rated proteins were transferred to PVDF membranes
(Bio-Rad). Expression of caspase-8, caspase-9, pro and
cleaved caspase-3, PARP, phospho-Akt, phospho-ERK1/
2, cyclin D1, cdk4, and b-actin was detected by incubat-
ing the PVDF membranes with primary antibodies
against these molecules followed by appropriate peroxi-
dase-conjugated secondary antibody incubation. Immu-
noreactive protein bands were detected using an
enhanced chemiluminescent (ECL) reagent (Thermo
Scientific Pierce). Images of immunoreactive protein
bands were captured using the Gel Doc 100 system with
Quantity One
® imaging software (Bio-Rad).
Statistical analysis
The half maximal inhibitory concentrations (IC50) of
Boswellia sacra essential oil were calculated from cell
viability assay using the curve fitting function in Sigma
Plot (Systac Software, San Jose, CA). Essential oil-
induced cytostatic and cytotoxic effects were expressed
as mean ± standard error of mean (SEM) from at least
four experiments. Comparisons of breast cancer cell via-
bility and death following essential oil treatment were
made using the one-way analysis of variance (ANOVA)
followed by Tukey multiple comparison test to compare
cell lines’ mean responses to essential oil treatment.
Results were considered statistically significant when P <
0.05.
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Chemical composition of Boswellia sacra essential oil
Chemical profiles for Boswellia sacra essential oils
obtained from different temperatures of hydrodistillation
demonstrated that a-pinene is the major compound
present in both temperatures preparations (Additional
File 1, Table S1). Contents of a-pinene decreased with
higher temperature distillation. In addition, essential oils
from both temperatures preparations were primarily
composed of the major monterpene, including a-thu-
jene, unidentified 1, b-pinene, and myrcene. In general,
all compounds with higher retention indices, with a few
exceptions, were present in higher quantities in essential
o i ld i s t i l l a t e da t1 0 0
oC as compared to that obtained at
78
oC.
Quantitatiion of boswellic acids
Since triterpene including boswellic acids could not be
detected by the current GC-MS protocol used in our
laboratory, an HPLC method was applied to determine
total boswellic acids in Boswellia sacra essential oils.
Contents of boswellic acids in essential oils depended
upon temperature of hydrodistillation. Higher distillation
temperature produced higher quantities of boswellic
acids; higher amounts of total boswellic acids were
detected in essential oil hydrodistilled at 100
oCa sc o m -
pared to 78
oC (Table 1).
Suppression of tumor cell-specific viability by Boswellia
sacra essential oils
Cell proliferation was determined in all four human
breast cell lines in the absence of Boswellia sacra essen-
tial oil. Under the culture condition used for each cell
line, the immortalized normal breast epithelial cells pro-
liferated faster than three breast cancer cell lines. Dou-
bling time for MCF10-2A cells was 12 hours as
compared to 20, 22, and 27 hours for T47D, MCF7, and
MDA-MB-231 cells, respectively; and MCF10-2A cell
numbers were significantly higher than T47D, MCF7, or
MDA-MB-231 cells at days 2, 3, and 4 following cell
seeding (Figure 1).
Boswellia sacra essential oils were studied for their
capabilities in suppressing breast cancer cell viability in
cultures. For essential oil collected at 78
oC, 200 to
1:1,600 dilutions were used, whereas a wider range of
dilutions (600 to 2,700) was used for essential oil col-
lected at 100
oC. Although different cancer cell lines
varied in their sensitivities to essential oil treatment,
both temperatures of essential oil preparations, in gen-
eral, suppressed cell viability in all three human breast
cancer cell lines (Figure 2). Boswellia sacra essential oil-
suppressed cancer cell viability depended upon hydro-
distillation temperatures. Essential oil obtained at 78
oC
possessed less potent anti-proliferative activity (Figure
2A) as compared to that prepared at 100
oC (Figure 2B).
More importantly, immortalized normal breast epithelial
MCF10-2A cells were resistant to Boswellia sacra essen-
tial oil-suppressed cell viability (Figure 2). MCF10-2A
cell viability was significantly higher than three breast
cancer cell lines when 600 to 1,200 dilutions of essential
oil (obtained at 100
oC) was administered; in contrast,
results were less significant when essential oil prepared
at 78
oC was used.
IC50 values were calculated to provide a quantitative
assess of these essential oils. Results supported that
essential oil hydrodistilled at 100
oCp r o d u c e dm o r e
potent cytotoxic effects. For example, IC50 values for
T47D cells were 900 and 1,450 dilutions for essential
oils obtained at 78 and 100
oC, respectively (Table 2).
Among the cancer cell lines, MCF7 cells were the most
sensitive to essential oil with suppressed cell viability.
Boswellia sacra essential oil-induced breast tumor cell-
specific death
In order to determine whether the reduced cell viability
resulted from increased cell death and how cells
responded at an early phase of treatment, essential oil-
induced breast cell death was quantified by LDH release.
Elevated cell death was observed in all three breast can-
cer cell lines treated with Boswellia sacra essential oils
(Figure 3). In contrast, essential oil-induced cytotoxicity
was significantly lower in immortalized MCF10-2A cells
at 3 hours after treatment. Consistent to results from cell
viability assays, Boswellia sacra essential oil prepared
from 78
oC hydrodistillation (Figure 3A) was less potent
than the essential oil obtained at 100
oC (Figure 3B) for
inducing an early phase of tumor cell-specific death.
Boswellia sacra essential oil-induced apoptosis
Fragmentation of genomic DNA demonstrated that Bos-
wellia sacra essential oil induced apoptosis in breast
cancer cells. Essential oils prepared at 78
oC (at 800
dilution) and 100
oC (at 1,200 dilution) induced geno-
mic DNA fragmentation in a time-dependent manner;
all three human breast cancer cell lines exhibited similar
patterns and visible fragmented genomic DNA within 8
hour post-treatment (Figure 4A). In contrast, the same
concentrations of essential oils treatment did not induce
DNA fragmentation in MCF10-2A cells.
Caspases, a family of cysteine proteases, play critical
roles in apoptosis. Cleaved caspase-8 p43/p41 and
Table 1 Boswellic acids contents in Boswellia sacra
essential oils
Specific gravity Total boswellic acids (mg/ml)
78
oC distillation 0.852 19.6
100
oC distillation 0.847 30.1
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Figure 1 Human breast cell growth. Human breast cancer cells and immortalized normal breast epithelial cells (1x10
3)w e r es e e d e di n
triplicate in their culture media, and quantified for their growth between 1 and 4 days following cell seeding. Cell numbers were calculated
from standard curves with known numbers of cells. Results are presented as mean ± SEM from 4 independent experiments. * indicates statistical
differences between normal and malignant cells at P < 0.05.
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Figure 2 Breast cell viability in response to Boswellia sacra essential oil exposure. Human breast cells (5x10
3) were seeded in each well of
96-well tissue culture plates in triplicate. Following adherence, cells were treated with Boswellia sacra essential oil hydrodistilled at (A) 78
oCo r
(B) 100
oC for 12 hours. Cell viability was determined using the colometric XTT assay at 24 hours after essential oil treatment. Data are presented
as mean ± SEM from at least 4 independent experiments. * indicates statistical differences between essential oil-treated breast cancer cells and
immortalized breast cells (P < 0.05).
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tial oil treated MDA-MB-231 cells (Figure 4B). Caspase-
3 is a key enzyme either partially or totally responsible
for the proteolytic cleavage of several target proteins
involved in executing apoptotic processes. Essential oil-
induced activated (cleaved) caspase-3 expression showed
prominent elevation of this protein corresponding to
decreases of pro-caspase-3 levels within 1 hour post-sti-
mulation by essential oils from both temperatures in
MDA-MB-231 cells. Cleavage of PARP, involved in
DNA repair following environmental stress [32] and a
main cleavage target of caspase-3 [33], was also detected
in MDA-MB-231 cells within 1 hour and 15 min follow-
ing treatment with essential oils obtained at 78 and 100
oC, respectively. In contrast, the same concentrations of
Boswellia sacra essential oils did not induce detectible
cleavage of caspase-8, caspase-9, caspase-3, or PARP in
T47D, MCF7, or MCF10-2A cells.
Anti-invasive activity of Boswellia sacra essential oil on
Matrigel
MDA-MB-231 cells were able to form networks of tubes
on Matrigel (Figure 5A and 5B). When cells were trea-
ted with essential oils at 1:800 (Figure 5C) and 1:1,500
(Figure 5E) dilutions obtained at 78 and 100
oCh y d r o -
distillation, respectively, the formation of cellular net-
works was reduced without inducing cytotoxicity.
Boswellia sacra essential oils completely blocked MDA-
MB-231 cell tube formation when 1:600 dilution of
essential oil obtained at 78
oC (Figure 5D) and 1:1,200
dilution of oil prepared at 100
oC( F i g u r e5 F )w e r e
applied, while cells remained viable on Matrigel based
on the XTT assay. In contrast, higher concentrations of
both essential oils (1:400 and 1:900 dilutions from 78
and 100
oC hydrodistillation, respectively) suppressed
both tube formation and viability of MDA-MB-231 cells
on Matrigel. In contrast, MCF10-2A cells did not form
capillary-like networks on Matrigel.
Boswellia sacra essential oil-suppressed multicellular
tumor spheroids growth
Essential oil was assessed for its capability in inducing
tumor cell death in three-dimensional multicellular
spheroids. Among the three breast cancer cell lines
tested, T47D was the only cell line that formed spher-
oids on the NanoCluture
® plates (Figure 6A). Treatment
of T47D cells with 1:800 dilution of essential oil
obtained at 78
oC( F i g u r e6 C )a sw e l la s1 : 1 , 5 0 0a n d
Table 2 IC50 values of Boswellia sacra essential oils on
human breast cells
Breast cell line Temperature of hydrodistillation
78°C 100°C
MCF10-2A 1:680* NA**
T47D 1:900 1:1,450
MCF7 1:1,000 1:1,800
MDA-MD-231 1:950 1:1,300
*numbers represent dilutions of essential oil
**NA: value is not available
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Figure 3 Quantitative analysis of Boswellia sacra essential oil-induced human breast cancer cell death.H u m a nb r e a s tc e l ll i n e sw e r e
seeded in each well of 96-well tissue culture plates at the concentration of 5x10
3 cells/well in triplicate. Following overnight adherence, cells
were treated with either Boswellia sacra essential oil hydrodistilled at (A) 78
oC or (B) 100
oC. Cell death was determined at 3 hours following
essential oil exposure by the LDH cytotoxicity detection kit. Data were presented as mean average numbers of dead cells ± SEM from at least 3
independent experiments. * indicates statistical differences of cell death between cancer cells and immortalized breast cells (P < 0.05).
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Page 7 of 141:1,200 dilutions obtained at 100
oC (Figure 6D and 6E)
blocked spheroids formation.
Boswellia sacra essential oil-regulated expression of
signaling molecules and cell cycle regulators
Essential oil-regulated Akt and ERK1/2 activation was
analyzed to determine the impacts of these oils on these
two important signaling pathways. Levels of phospho-
Akt (Ser473) were immediately suppressed by essential
oil obtained at 78
oC in all breast cancer cell lines. In
contrast, T47D and MCF7 cells responded with elevated
levels of phospho-Akt (Ser473) expression within 15
min and gradually decreased thereafter when cells were
treated with essential oil obtained at 100
oC( F i g u r e7 ) .
Essential oils suppressed phosphorylated levels of ERK1/
2 (Thr202/Tyr204) expression in T47D and MCF7 cells,
whereas MDA-MB-231 cells responded with immediate
up-regulation within 15 min and returned to untreated
levels thereafter. In contrast, MCF10-2A cells did not
have detectible phosporylated ERK1/2 expression, and
their phosphorylated Akt expression was not altered by
essential oil treatment.
Boswellia sacra essential oil also regulated the expres-
sion of cell cycle regulators, cdk4 and cyclin D1. Levels
of cdk4 expression were gradually suppressed by essen-
tial oil obtained at 78
oC in all 3 breast cancer cell lines,
whereas cdk4 expression maintained relatively constant
when T47D and MDA-MB-231cells were treated with
oil distilled at 100
oC (Figure 7). Cyclin D1 is a crucial
cell cycle regulator in human breast cancer cells. All
three breast cancer cell lines responded to essential oils
with suppressed cyclin D1 expression. MCF10-2A cells
did not respond to essential oil treatment with altered
cdk4 expression, and had no detectible cyclin D1
expression.Discussion
The genus Boswellia consists of 18 genera and 540
species that grow mostly in tropical regions of America,
China, India, North Africa, and Arabia. Each species of
Boswellia produces a slightly different type of resin; and
differences in soil and climate create more diversity in
the resins, even within the same species. Although there
are many commercial brands of essential oils from dif-
ferent species of Boswellia for aromatherapy practices,
conditions for manufacturing these commercial essential
oils are not consistent or standardized. We previously
reported that Boswellia cateri essential oil possesses
human bladder cancer cell-specific anti-proliferative and
pro-apoptotic activities. In this communication, essential
oil was prepared by hydrodistillating Omani Boswellia
sacra resins at two temperatures and characterized their
effectiveness in suppressing breast cancer cell-specific
viability, apoptosis, invasion, drug resistance, and related
signaling pathways in vitro.
Chemical composition of Boswellia sacra essential oils
obtained from 78 and 100
oC hydrodistillation were
quantitatively and quantitatively characterized using
GC-MS and HPLC. In general, Boswellia sacra essential
o i lo b t a i n e da t1 0 0
oC hydrodistillation contains higher
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Figure 4 Boswellia sacra essential oil-induced apoptosis in human breast cancer cells. Human breast cancer MDA-MB-231 cells were
seeded at the concentration of 5x10
5 cells/60 mm tissue culture plates for adherence and subjected essential oils (1:800 and 1:1,200 dilutions of
78 and 100
oC, respectively) treatment. Both genomic DNA and total cellular proteins were isolated at specific time points as indicated. (A)
Essential oil-induced genomic DNA fragmentation. (B) Essential oil-activated pro- and cleavage of caspases. Experiments were repeated at least
twice and representative results are presented.
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Page 8 of 14quantities of chemical compounds with retention time
longer than sabinene as compared to essential oil pre-
pared at 78
oC. Boswellic acids from Boswellia sp. resins
have been suggested to be a major compound in med-
iating various biological functions including anti-inflam-
matory and anti-cancer activities. It has been shown
that b-boswellic acids from methanol extracts of Boswel-
lia cateri gum resins exhibit potent cytotoxic activities
against human neuroblastoma cell lines, IMR-32, NB-39,
and SK-N-SH [12]. Shao et al. compared 4 triterpene
acids including b-boswellic acid, 3-O-acetyl-b-boswellic
acid, 11-keto-b-boswellic acid, and AKBA isolated from
Boswellia serrata gum resins for their ant-cancer activity
in vitro. AKBA is the most pronounced inhibitory effects
among the 4 triterpene acids in suppressing human leu-
kemia HL-60 cell growth as well as DNA, RNA, and
protein synthesis [16]. AKBA also exhibits anti-prolifera-
tive and pro-apoptotic activities against human prostate
cancer LNCaP and PC-3 cells in vitro and in animal
models [21,34], and induces cytotoxicity in human
meningioma cells in culture [15]. Higher boswellic acids
contents are present in essential oil hydrodistilled at
higher temperature. However, our results suggest that
high molecular weight compounds other than boswellic
acids may play significant roles in suppressing tumor
cell viability and invasion. First, although shelf life con-
tents of boswellic acids decreased, Boswellia sacra essen-
tial oil-mediated tumor cell cytotoxicity remained
constant during the same period of time. Second, hydro-
sol, the aqueous phase of hydrodistilled products, con-
tained up to 15.5% boswellic acids, but did not have
detectible cytoxicity against breast cancer cells even
when a 1:5 dilution was included in the cell cultures.
Our results are in accordance with the report by Hos-
tanska et al. that components other than AKBA from
solvent extracts of Boswellia serrata gum resins can
induce cytotoxicity in malignant cells [10]. Additionally,
Estrada et al. reported that tirucallic acids purified from
Boswellia carteri gum resins induce apoptosis in human
prostate cancer cell lines [35]. Although the active
A C 
F  B D 
E 
Figure 5 Assessment of anti-invasive activity of Boswellia sacra essential oil. Matrigel basement membrane matrix (100 μl) was transferred
to each well of 96-well culture plates and allowed to polymerize at 37
oC. MDA-MB-231 cells (4 × 10
4) were resuspended in 100 µl growth
media and added on the top of the polymerized Matrigel (A and B). In separate wells, cells were either mixed with 100 µl of 78
oC essential oil
at (C) 1:800 or (D) 1:600 dilution, or 100
oC essential oil at (E) 1:1,500 or (F) 1:1,200 dilution and layered on the top of Matrigel. Formation of
vascular-like networks was assessed at 24 hours following oil treatment. The capabilities of MDA-MB-231 cells in forming networks of tubes and
Boswellia sacra essential oil in suppressing the cellular network formation on Matrigel are observed at 100× magnification. Experiments were
repeated at least 3 times and representative images are presented.
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Page 9 of 14compound(s) in Boswellia sacra essential oil responsible
for anti-tumor activity cannot be identified immediately
due the complexity of essential oils, chemical composi-
tions and/or ratios of these components present in the
oil obtained at 100
oC would play significant roles in
tumor cell-specific cytotoxicity.
Commonly, cancer chemotherapy drugs, including
alkylating antineoplastic agent [36], antimetabolite [37],
and anthracycline [38], act by impairing cell viability in
rapidly dividing cells. Under the cell culture conditions
used in this report, immortalized normal breast epithe-
lial MCF10-2A cells proliferate significantly faster than
breast cancer T47D, MCF7, or MDA-MB-231 cells.
However, all cancer cell lines are more sensitive to Bos-
wellia sacra essential oil treatment as compared to the
immortalized normal cells. Consistently, human bladder
cancer cells [39] and colonic cancer cells (data not
s h o w n )a r em o r es e n s i t i v et oBoswellia sp. essential oil
with elevated cytotoxicity and apoptosis as compared to
their normal counterparts. Boswellia sp.e s s e n t i a lo i l
may possess certain unique components that specifically
target and induce programmed cell death in malignant
cells. The absence of activated caspase-3 expression in
T47D and MCF7 cells suggests that essential oil-induced
apoptosis may activate a caspase-3-independent pathway
similar to taxol-induced apoptosis in breast carcinoma
MCF7 cells [40].
Boswellia sacra essential oil also suppresses important
malignant features of tumor cells, such as invasion and
multicellular tumor spheroids growth. Tumor cell plasti-
city enables highly malignant tumor cells to express
endothelial cell-specific markers and form vessel-like
network structures on basement membranes. The in
vitro Matrigel-based tumor invasion model has been
shown to correlate with in vivo metastatic potential [41].
This in vitro model has been used to study mechanisms
of cancer aggressive behavior, metastasis, and poor
prognosis [42], and has been used as a tool to screen
therapeutic agents for their anti-metastatic property
[30,43]. MDA-MB-231 cells grown on Matrigel are
more resistant to essential oil-suppressed cell viability as
compared to cells grown on tissue culture plates. These
differences may result from protective effects of the
Matrigel basement membrane matrix enriched with
A B 
C 
D 
E 
Figure 6 Capability of Boswellia sacra essential oil in suppressing multicellular spheroid growth. Breast cancer T47 cells (1 × 10
4)w e r e
seeded into each well of the 96-well NanoCulture
® plates. Following the formation of spheroids, cells were either (A) left untreated or treated
with 78
oC essential oil at (B) 1:800 or (C) 1:600 dilution, or 100
oC essential oil at (D) 1:1,500 or (E) 1:1,200 dilution. Spheroids images were
captured at 24 hours following essential oil treatment at 100x magnification. Experiments were repeated at least 3 times and representative
images are presented.
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Figure 7 Boswellia sacra essential oil-regulated signaling molecules activation and cell cycle-related proteins expression in human
breast cancer cells. Breast cancer cells were seeded at the concentration of 5 × 10
5 cells/60 mm tissue culture plate. After adherence, cells
were treated with either 1:800 dilution of 78
oC or 1:1,200 dilution of 100
oC essential oil. Total cellular proteins were isolated between 0
(untreated control) and 4 hours following essential oils treatment. Western blot analysis was performed to determine levels of Akt and ERK1/2
phosphorylation as well as cyclin D1 and cdk4 proteins expression. Expression of b-actin was also determined in parallel and used as a protein
loading control. Experiments were repeated at least twice for each cell line and representative results are presented.
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Page 11 of 14various growth factors. In addition, cancer cells can
form multicellular spheroid aggregates, which afford
protection of cancer cells against some chemotherapeu-
tic agents [44]. Multicellular tumor spheroids in culture
have been used as an in vitro model for screening and
testing anti-cancer drugs [45]. Similar to results from
cytotoxicity and apoptosis, Boswellia sacra essential oil
obtained at 100
oC is more potent than essential oil
obtained at 78
oC hydrodistillation in disruption cellular
networks on Matrigel and spheroids. More importantly,
observations obtained in the above described experi-
mental models are consistent with clinical responses in
human cancer cases; and clinical case studies will be
reported separately. These results suggest that Boswellia
sacra essential oil may represent an effective therapeutic
agent for treating invasive breast cancer.
Aberrant activations of Akt and ERK1/2 MAPK signal-
ing molecules have been identified in various cancers
including breast cancer; and activations of Akt and
ERK1/2 have been suggested as independent cancer
prognostic markers. The Akt pathway is found to be acti-
vated in early stages of breast cancer development [46];
and activation of Akt signaling protects breast cancer
cells from tamoxifen-induced apoptosis in vitro and con-
fers poor prognosis in cancer patients [47,48]. Activation
of ERK1/2 is also shown to be associated with the devel-
opment of tamoxifen resistant and patient survival
[49,50]. Both Akt and ERK1/2 have been proposed as
molecular targets for treating breast cancer particularly
in antiestrogen-resistant states [51,52]. Targeting Akt sig-
naling by inhibiting mTRO signaling has been shown to
restore cancer responses to chemotherapy drugs [53,54];
and inhibition of both epidermal growth factor receptor
(EGFR)/HER2 and MAPK signaling has been shown to
result in growth inhibition and apoptosis of EGFR-
expressing breast cancer cells [55]. Studies have shown
that boswellic acids and AKBA activate the PI3K/Akt
pathway in human colon cancer HT29 cells [56].
Although AKBA was reported to rapidly and potently
inhibit the phosphorylation of ERK1/2 in primary cul-
tures of meningioma cells [15], other studies showed that
boswellic acids and AKBA activate ERK1/2 in human
polymorphonuclear leukocytes and platelets [57,58]. Our
results demonstrate that Boswellia sacra essential oil sup-
presses Akt and ERK1/2 activation in human breast can-
cer cell lines except MDA-MB-231 cells. The differences
between boswellic acids and Boswellia sacra essential oil
may result from different tumor cell types or components
other than boswellic acids in the essential oil.
The majority of human mammary carcinomas overex-
press cyclin D1 protein [59,60]; and overexpression of
cyclin D1 has been shown to be correlated to breast
cancer development and progression, including meta-
static lesions [61,62]. Among many different cyclin D1
interactors, the cdk4 gene is found to be amplified and
the protein to be overexpressed in a significant fraction
of human breast cancer cases [63-65]; and the continued
presence of cdk4-associated kinase activity is required to
maintain breast tumorigenesis [66]. Therefore, cyclin
D1-cdk4 has been proposed as a target for therapeutic
intervention in mammary carcinomas. A highly specific
inhibitor of cdk4/6 activity (PD-0332991) has been
developed and evaluated for its efficacy in the treatment
of breast cancer [67]. Boswellic acids, including AKBA,
have been shown to arrest cancer cells at the G1 phase
of cell cycle, suppresses cyclin D1 and E, cdk 2 and 4, as
well as phosphorylated Rb and increased p21 expression
through a p53-independent pathway [22,68,69]. Consis-
tently, our results demonstrate that Boswellia sacra
essential oil suppresses cyclin D1 and cdk4 expression
in almost all breast cancer cell lines examined. Biologi-
cal significances between essential oil-regulated PI3K/
Akt and ERK1/2 activation, cdk4 and cyclin D1 expres-
sion, tumor cell cytotoxicity require further studies.
Boswellia sacra essential oil-activated cell death path-
ways are still under intensive investigation. Pathways that
are activated by a mixture of chemical components in
essential oil are expected to more complicate than the
results presented in this communication. In our previous
report, using Boswellia cateri essential oil, multiple genes
and pathways that are associated with suppression of cell
proliferation and cell cycle progression, as well as increase
of apoptosis in human bladder cancer J82 cells were char-
acterized [39]. Using a comprehensive gene expression
analysis in J82 cells treated with Boswellia cateri essential
oil, bioinformatics results suggest that the Nrf2-mediated
oxidative stress pathway appears is the most plausible
cause for selective cancer cell death (data not shown). Bos-
wellia sp. essential oil may selectively eradicate cancer
cells via suppressing intracellular accumulation reactive
oxygen radicals as reported in other models [70,71].
Conclusion
We have demonstrated that Boswellia sacra essential oil
prepared from hydrodistillation has tumor cell-specific
cytotoxicity in multiple cancer cell types. Consistent
with anti-proliferative, pro-apoptotic, and anti-invasive
activities in cultured breast cancer cells, Boswellia sacra
essential oil is shown to induce tumor cell cytotoxicity
in a drug resistant and metastasized breast cancer case.
In addition to establishing standard procedures to pro-
duce essential oil with consistent chemical composition,
safety and toxicity studies of the oil and pre-clinical vali-
dation of the in vitro results will be required. Moreover,
formulation and standardization of clinical protocols to
monitor cancer progression following Boswellia sacra
essential oil administration are needed immediately for
prospective human clinical trials.
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Additional file 1: Table S1. Chemical composition of Boswellia sacra
essential oil. Chemical components of essential oil quantified by GC-MS.
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